BRPI0618713B8 - cardiolipina modificada e seus usos - Google Patents

cardiolipina modificada e seus usos

Info

Publication number
BRPI0618713B8
BRPI0618713B8 BRPI0618713A BRPI0618713A BRPI0618713B8 BR PI0618713 B8 BRPI0618713 B8 BR PI0618713B8 BR PI0618713 A BRPI0618713 A BR PI0618713A BR PI0618713 A BRPI0618713 A BR PI0618713A BR PI0618713 B8 BRPI0618713 B8 BR PI0618713B8
Authority
BR
Brazil
Prior art keywords
antibodies
cardiolipin
treponemic
allow
detection
Prior art date
Application number
BRPI0618713A
Other languages
English (en)
Inventor
r castro Arnold
Wang Huiying
Original Assignee
The Government Of The United State Of America Representado Por The Secretary Of The Dept Of Health A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Government Of The United State Of America Representado Por The Secretary Of The Dept Of Health A filed Critical The Government Of The United State Of America Representado Por The Secretary Of The Dept Of Health A
Publication of BRPI0618713A2 publication Critical patent/BRPI0618713A2/pt
Publication of BRPI0618713B1 publication Critical patent/BRPI0618713B1/pt
Publication of BRPI0618713B8 publication Critical patent/BRPI0618713B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

cardiolipina modificada e seus usos. são descritas composições, métodos e dispositivos para a detecção de anticorpos anti-lipídicos e para o diagnóstico de doenças como, por exemplo, a sífilis. em particular, são descritas cardiolipinas oxidadas, que podem ser conjugadas com uma variedade de moléculas de ligação, tais como asb, hff, biotina, proteína sintética maps, igy, estreptavidina ou avidina. tal cardiolipina oxidada, isolada ou complexada com uma ou mais moléculas de ligação, é útil para detectar anticorpos anti-lipídios em sujeitos, por exemplo, quando utilizada em dispositivos de fluxo lateral. são descritos dispositivos de fluxo lateral que permitem a detecção de anticorpos anti-lipídicos, e que permitem a co-detecção de anticorpos não-treponêmicos e treponêmicos em amostras biológicas.
BRPI0618713A 2005-11-18 2006-11-17 cardiolipina modificada e seus usos BRPI0618713B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73790105P 2005-11-18 2005-11-18
US60/737,901 2005-11-18
PCT/US2006/044572 WO2007061793A2 (en) 2005-11-18 2006-11-17 Modified cardiolipin and uses therefor

Publications (3)

Publication Number Publication Date
BRPI0618713A2 BRPI0618713A2 (pt) 2012-12-04
BRPI0618713B1 BRPI0618713B1 (pt) 2018-01-02
BRPI0618713B8 true BRPI0618713B8 (pt) 2021-07-27

Family

ID=38067762

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0618713A BRPI0618713B8 (pt) 2005-11-18 2006-11-17 cardiolipina modificada e seus usos

Country Status (6)

Country Link
US (2) US7888043B2 (pt)
EP (1) EP1949108B1 (pt)
JP (2) JP4837743B2 (pt)
CN (1) CN101360997B (pt)
BR (1) BRPI0618713B8 (pt)
WO (1) WO2007061793A2 (pt)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778619B2 (en) 2005-11-18 2014-07-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Oxidized cardiolipin and uses to detect cardiolipin antibodies
US9903864B2 (en) 2009-04-09 2018-02-27 Arkray, Inc. Sample analysis tool, method for producing sample analysis tool, and method for inhibiting decrease in liquid permeability of development member
CN101762694A (zh) * 2009-06-24 2010-06-30 北京科美东雅生物技术有限公司 一种检测hcv抗体的磁性免疫层析试纸条及其制备方法
CN101762698A (zh) * 2009-06-24 2010-06-30 北京科美东雅生物技术有限公司 一种定量检测血液中肿瘤相关抗原19-9的磁性免疫层析试纸条及制备方法
FI3489685T3 (fi) * 2011-11-21 2023-12-21 Zoetis Services Llc Signaalin vahvistaminen lateraalivirtaus- ja vastaavissa immunomäärityksissä
CN102830229B (zh) * 2012-08-27 2014-12-17 北京新兴四寰生物技术有限公司 梅毒螺旋体IgM抗体胶体金法检测试剂及其制备方法
CN103130867A (zh) * 2013-01-25 2013-06-05 丁伟丽 一种链霉亲和素偶联物的制备方法
JP6026305B2 (ja) 2013-02-04 2016-11-16 古河電気工業株式会社 標識抗体の製造方法
CN104049081B (zh) * 2013-03-13 2016-03-09 意识科技股份有限公司 针对梅毒抗体的血清学方法和诊断测试
US8945827B2 (en) 2013-03-13 2015-02-03 Awareness Technology, Inc. Serological methods and diagnostic tests for syphilis antibodies
EP3019559A4 (en) 2013-08-22 2017-04-05 Sony Corporation Water soluble fluorescent or colored dyes and methods for their use
CN104330566B (zh) * 2013-10-14 2016-07-06 赵磊 梅毒试纸条及其制备方法、梅毒检测卡及其制备方法
GB2523114A (en) * 2014-02-12 2015-08-19 Kratos Analytical Ltd Oxidized lipid detection
JP5767362B1 (ja) * 2014-04-25 2015-08-19 田中貴金属工業株式会社 免疫クロマト分析装置、免疫クロマト分析方法及び免疫クロマト分析キット
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
US20180258113A1 (en) 2014-11-26 2018-09-13 Syddansk Universitet Novel artificial phospholipid-protein bioconjugates for biomolecular recognition
US11827661B2 (en) 2015-02-26 2023-11-28 Sony Group Corporation Water soluble fluorescent or colored dyes comprising conjugating groups
WO2016144962A1 (en) 2015-03-10 2016-09-15 Bio-Rad Laboratories, Inc. Combination treponemal and non-treponemal syphilis test
CA2991532C (en) 2015-08-04 2024-03-05 Abaxis, Inc. Signal amplification in solution-based plasmonic specific-binding partner assays
WO2017108115A1 (en) * 2015-12-22 2017-06-29 Centre National De La Recherche Scientifique - Cnrs - Device for detecting neurotoxins and process for manufacture thereof
RU2633087C2 (ru) * 2016-03-23 2017-10-11 Сейфаддин Гашим Оглы Марданлы Стабилизированный кардиолипиновый антиген для реакции микропреципитации при диагностике сифилиса и способ его получения
CN109415574B (zh) 2016-04-01 2021-05-28 索尼公司 具有刚性间隔基团的超亮二聚体或聚合物染料
AU2017240154B2 (en) 2016-04-01 2021-08-12 Sony Group Corporation Ultra bright dimeric or polymeric dyes
WO2017177065A2 (en) 2016-04-06 2017-10-12 Sony Corporation Ultra bright dimeric or polymeric dyes with spacing linker groups
EP3455299B1 (en) 2016-05-10 2024-01-17 Sony Group Corporation Compositions comprising a polymeric dye and a cyclodextrin and uses thereof
JP7527537B2 (ja) 2016-05-10 2024-08-05 ソニーグループ株式会社 ペプチド骨格を有する超明色ポリマー染料
EP3455300A1 (en) 2016-05-11 2019-03-20 Sony Corporation Ultra bright dimeric or polymeric dyes
EP3464477A1 (en) 2016-06-06 2019-04-10 Sony Corporation Ionic polymers comprising fluorescent or colored reporter groups
KR102208218B1 (ko) * 2016-06-30 2021-01-26 선전 와이에이치엘오 바이오텍 캄파니 리미티드 변형된 카디오리핀으로 코팅된 마그네틱 나노비드 및 그 제조 방법
CN106198956B (zh) * 2016-06-30 2018-04-20 深圳市亚辉龙生物科技股份有限公司 改性心磷脂包被的纳米磁珠及其制备方法
CN106198957B (zh) * 2016-06-30 2018-10-02 深圳市亚辉龙生物科技股份有限公司 改性心磷脂包被的纳米磁珠及其制备方法
US11619629B2 (en) 2016-06-30 2023-04-04 Shenzhen Yhlo Biotech Co., Ltd. Modified cardiolipin-coated magnetic nanobeads and preparation methods therefor
CN106124783B (zh) * 2016-06-30 2018-10-02 深圳市亚辉龙生物科技股份有限公司 改性心磷脂包被的纳米磁珠及其制备方法
EP3480594A4 (en) * 2016-06-30 2020-03-11 Shenzhen Yhlo Biotech Co., Ltd. MODIFIED CARDIOLIPIN COATED MAGNETIC NANO BALLS AND PRODUCTION METHOD THEREFOR
JP7312929B2 (ja) 2016-07-29 2023-07-24 ソニーグループ株式会社 超明色二量体またはポリマー色素およびその調製のための方法
CN118275398A (zh) 2017-01-30 2024-07-02 硕腾服务有限责任公司 基于溶液的等离子体振子特异性结合配偶体测定和金属纳米结构
US11179312B2 (en) 2017-06-05 2021-11-23 Momentive Performance Materials Inc. Aqueous compositions for the treatment of hair
WO2019071153A1 (en) 2017-10-05 2019-04-11 Sony Corporation PROGRAMMABLE DENDRITIC MEDICINES
KR20260011205A (ko) 2017-10-05 2026-01-22 소니그룹주식회사 프로그램가능한 중합체성 약물
CN111836645A (zh) 2017-11-16 2020-10-27 索尼公司 可编程的聚合药物
US12539334B2 (en) 2018-01-12 2026-02-03 Sony Group Corporation Phosphoalkyl polymers comprising biologically active agents
CN111565756A (zh) 2018-01-12 2020-08-21 索尼公司 包含生物活性化合物的具有刚性间隔基团的聚合物
EP3737417B1 (en) 2018-01-12 2025-08-27 Sony Group Corporation Phosphoalkyl ribose polymers comprising biologically active compounds
KR102742386B1 (ko) 2018-03-19 2024-12-16 소니그룹주식회사 형광 신호 향상을 위한 2가 금속의 사용
CN118480073A (zh) 2018-03-21 2024-08-13 索尼公司 具有连接体基团的聚合串联染料
CN108333374A (zh) * 2018-04-08 2018-07-27 广州天宝颂原生物科技开发有限公司 C-反应蛋白、血清淀粉样蛋白a免疫层析定量联合检测试纸条及其制备方法
JP7580689B2 (ja) 2018-06-27 2024-11-12 ソニーグループ株式会社 デオキシリボースを含むリンカー基を有するポリマー色素
KR20210032434A (ko) 2018-07-13 2021-03-24 소니 주식회사 유기인산염 단위를 포함하는 백본을 갖는 중합체성 염료
WO2020111028A1 (ja) * 2018-11-26 2020-06-04 株式会社カネカ ゲノム編集方法
US11090255B2 (en) 2018-12-04 2021-08-17 Momentive Performance Materials Inc. Use of polycarboxylic acid compounds for the treatment of fibrious amino acid based substrates, especially hair
WO2021062176A2 (en) 2019-09-26 2021-04-01 Sony Corporation Polymeric tandem dyes with linker groups
EP4038081A1 (en) 2019-09-30 2022-08-10 Sony Group Corporation Nucleotide probes
CN111220808A (zh) * 2019-12-02 2020-06-02 郑州安图生物工程股份有限公司 一种tp螺旋体非特异性抗体检测试剂盒
US12174123B2 (en) 2020-06-11 2024-12-24 Mehdi Hatamian Lateral flow assay housing and method of correcting color, intensity, focus, and perspective of an image of the test results
US11275020B2 (en) * 2020-06-11 2022-03-15 Mehdi Hatamian Lateral flow assay housing and method of correcting color, intensity, focus, and perspective of an image of the test results
CN111983221B (zh) * 2020-08-19 2024-04-09 深圳市卓润生物科技有限公司 表面修饰磁珠及其制备方法和应用
EP4256078A1 (en) 2020-12-07 2023-10-11 Sony Group Corporation Spacing linker group design for brightness enhancement in dimeric or polymeric dyes
CN114195821B (zh) * 2021-12-17 2024-03-12 郑州安图生物工程股份有限公司 一种心磷脂衍生物及其制备方法和应用
CN117288948B (zh) * 2023-06-19 2024-06-04 无锡嘉润诊断技术有限公司 抗凝血酶原抗体检测试剂盒

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3564089A (en) 1966-09-29 1971-02-16 Sandra Jean Kiddy Diagnostic reagent for syphilis
CA1086225A (en) 1976-03-18 1980-09-23 Masuo Aizawa Syphilis antibody diagnosis by antigen membrane and potentiometric method
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
NL7807532A (nl) 1978-07-13 1980-01-15 Akzo Nv Metaal-immunotest.
NL8000173A (nl) 1980-01-11 1981-08-03 Akzo Nv Toepassing van in water dispergeerbare, hydrofobe kleurstoffen als label in immunochemische testen.
US4740467A (en) 1982-05-26 1988-04-26 Board Of Regents, The University Of Texas Methods for diagnosing syphilis
AU2706384A (en) 1983-05-06 1984-11-08 Monoclonal Antibodies Inc. Colorimetric immunoassay on solid surface
US4738932A (en) 1985-12-03 1988-04-19 Advanced Polymer Systems, Inc. Reaginic test for syphilis
US4894328A (en) 1986-03-26 1990-01-16 Board Of Regents, The University Of Texas System Immunodiagnostic test for syphilis and other treponemal infections
EP0282192A1 (en) 1987-03-09 1988-09-14 Quidel Competitive immunoassay for haptens using protein-hapten coupled solid phase
US4954452A (en) 1987-07-09 1990-09-04 Abbott Laboratories Non-metal colloidal particle immunoassay
AU5262390A (en) * 1989-02-27 1990-09-26 Biostar Medical Products, Inc. Method and diagnostic test kit for detection of anti-cardiolipin
JPH04503865A (ja) * 1989-12-27 1992-07-09 バクスター、ダイアグノスティックス、インコーポレイテッド カルジオリピン、フォスファチジルコリン及びコレステロールを固相に固定化する方法及びイムノアッセイ
US6261792B1 (en) 1990-12-07 2001-07-17 The Liposome Company, Inc. Lipid-dependent diagnostic assays
CA2072548A1 (en) 1992-06-26 1993-12-27 Michael W. Stewart Methods for determining antiphospholipid antibodies
WO1995009363A1 (en) 1993-09-29 1995-04-06 Yamasa Corporation Method of assaying oxidized lipoprotein and application thereof
US5780319A (en) 1996-04-19 1998-07-14 Pasteur Sanofi Diagnostics Immunoassays to detect antiphospholipid antibodies
US5798273A (en) * 1996-09-25 1998-08-25 Becton Dickinson And Company Direct read lateral flow assay for small analytes
US6258548B1 (en) 1997-06-05 2001-07-10 A-Fem Medical Corporation Single or multiple analyte semi-quantitative/quantitative rapid diagnostic lateral flow test system for large molecules
US6177282B1 (en) * 1997-08-12 2001-01-23 Mcintyre John A. Antigens embedded in thermoplastic
JPH11258236A (ja) * 1998-03-09 1999-09-24 Sekisui Chem Co Ltd 抗リン脂質抗体測定試薬
US6214629B1 (en) 1998-08-06 2001-04-10 Spectral Diagnostics, Inc. Analytical test device and method for use in medical diagnoses
RU2244933C2 (ru) * 1999-06-09 2005-01-20 ПРАВИТЕЛЬСТВО СОЕДИНЕННЫХ ШТАТОВ АМЕРИКИ, представляемое СЕКРЕТАРЕМ МИНИСТЕРСТВА ЗДРАВОХРАНЕНИЯ И СЛУЖБЫ ДЛЯ ЛЮДЕЙ Антигенная композиция и способ обнаружения присутствия treponema pallidum у человека
USRE43914E1 (en) 1999-06-09 2013-01-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Method for detecting syphilis using synthetic antigens
JP3713178B2 (ja) * 2000-02-14 2005-11-02 積水化学工業株式会社 梅毒抗体検出用免疫分析装置
US6372516B1 (en) 2000-09-07 2002-04-16 Sun Biomedical Laboratories, Inc. Lateral flow test device
GB0104057D0 (en) 2001-02-20 2001-04-04 Babraham Inst Antiphospholipid antibody syndrome
JP3911200B2 (ja) * 2002-05-24 2007-05-09 和光純薬工業株式会社 イムノクロマト測定法用感度増強剤、測定法及び測定法用器具
DE10250368A1 (de) * 2002-10-29 2004-05-19 Viramed Biotech Ag Mittel und Verfahren zur Diagnose einer Treponemainfektion
US8148057B2 (en) 2005-06-21 2012-04-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Methods, immunoassays and devices for detection of anti-lipoidal antibodies
CN101243321A (zh) 2005-06-21 2008-08-13 美国政府健康及人类服务部，疾病控制和预防中心 用于检测抗-类脂抗体的方法、免疫测定法和装置

Also Published As

Publication number Publication date
US20080311597A1 (en) 2008-12-18
US8906603B2 (en) 2014-12-09
US7888043B2 (en) 2011-02-15
EP1949108A2 (en) 2008-07-30
JP2009516199A (ja) 2009-04-16
JP5307198B2 (ja) 2013-10-02
BRPI0618713B1 (pt) 2018-01-02
JP2011237443A (ja) 2011-11-24
BRPI0618713A2 (pt) 2012-12-04
EP1949108B1 (en) 2013-09-25
CN101360997B (zh) 2013-05-01
WO2007061793A2 (en) 2007-05-31
US20110136143A1 (en) 2011-06-09
CN101360997A (zh) 2009-02-04
JP4837743B2 (ja) 2011-12-14
WO2007061793A3 (en) 2007-08-09

Similar Documents

Publication Publication Date Title
BRPI0618713B8 (pt) cardiolipina modificada e seus usos
BRPI0923199B8 (pt) método para determinar a presença de anticorpos de fixação de complemento
BR112013003391A2 (pt) biomarcadores de câncer pancreático e usos dos mesmos
ATE411525T1 (de) Nachweis einer histonmodifikation in zellfreien nukleosomen
BRPI0114343B8 (pt) método para detecção de imunoglobulina ige e para diagnóstico in vitro de alergias, bem como chip de microarranjo e kit que o compreende
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
BR112016010106A2 (pt) ensaios para igfbp7 com melhor desempenho em amostras biológicas
BR112012009846A2 (pt) ensaios para detecção de anticorpos específicos para anticorpos anti-ige terapêuticos e seu uso em anafilaxia
BR112016002685A2 (pt) ensaios para timp2 que apresentam melhor desempenho em amostras biológicas
SG179468A1 (en) Improved monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
BR112012009291A2 (pt) sistema de reconhecimento de subenchimento para um biossensor
MX2009013009A (es) Inmunoensayos de alta sensibilidad y kits para la determinacion de peptidos y proteinas de interes biologico.
BRPI0812875A2 (pt) " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ".
SG170051A1 (en) T cell assays
BR112014020513A2 (pt) Métodos e sistemas para amplificação de sinal de bioensaios
BR0317394A (pt) Uso de nicotinamida n-metiltransferase como um marcador para câncer colorretal
KR890702039A (ko) 1,25-디하이드록시 비타민 d의 분석 방법
WO2005114218A3 (en) Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
ZA201705365B (en) Homogenous immunoassay with compensation for background signal
BRPI0606529A2 (pt) método para a detecção da presença de um prìon patogênico em uma amostra e controle e substituto para uso em um ensaio de detecção de prìon
ATE469351T1 (de) Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c
ES2161011T3 (es) Reactivos para ensayo de ion diazonio y metodos para su utilizacion.
EP2565647A4 (en) REAGENT TO TEST AN ANTIBODY AGAINST TREPONEMA PALLIDUM
DE602008003850D1 (de) Verfahren und Kits zur Erkennung und Messung von ADAMTS13/FX1-Komplexen

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/11/2006, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2854 DE 16-09-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.